APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 82 filers reported holding APTEVO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $55,000 | -33.7% | 93,902 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $83,000 | -2.4% | 93,902 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $85,000 | -28.6% | 93,902 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $119,000 | -75.1% | 93,902 | 0.0% | 0.00% | -60.0% |
| Q3 2018 | $477,000 | +1.7% | 93,902 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $469,000 | +52.8% | 93,902 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $307,000 | +58.2% | 93,902 | +105.0% | 0.00% | +50.0% |
| Q4 2017 | $194,000 | +84.8% | 45,802 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $105,000 | +10.5% | 45,802 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $95,000 | +53.2% | 45,802 | +52.9% | 0.00% | 0.0% |
| Q1 2017 | $62,000 | – | 29,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,920,368 | $4,686,000 | 0.88% |
| Fondren Management LP | 388,355 | $948,000 | 0.68% |
| Perceptive Advisors | 988,133 | $2,411,000 | 0.17% |
| CSS LLC/IL | 353,977 | $864,000 | 0.05% |
| GLG Partners LP | 357,834 | $873,000 | 0.04% |
| Acrospire Investment Management LLC | 23,144 | $56,000 | 0.02% |
| Laurel Wealth Advisors, Inc. | 16,850 | $41,000 | 0.02% |
| Capital Impact Advisors, LLC | 12,318 | $30,000 | 0.01% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 43,559 | $106,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $24,000 | 0.01% |